Time New York: Thu 23 Nov 18:44 pm  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Globus Medical (GMED) Looks Good: Stock Adds 7.5% in Session

Zacks

Globus Medical, Inc. GMED was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $28.86–$31.87 in the past one-month time frame, witnessed a sharp increase yesterday.

The company's shares rallied after the company reported year-over-year growth in third-quarter earnings and revenues.

The company has seen no estimate revisions over the past one month, and the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Globus Medical currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.


Globus Medical, Inc. Price and Consensus

A better ranked stock in the Medical – Instruments industry is Luminex Corporation.LMNX which also carries a Zacks Rank #1 (Strong Buy) . You can see the complete list of today’s Zacks #1 Rank stocks here.

Is GMED going up? Or down? Predict to see what others think: Up or Down

More Stock News: This Is Bigger than the iPhone

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.